Coherus Biosciences | Despesas De Vendas E Administração


Selling And Administration Expenses Alterar Data
AbbVie USD 3.25B 40M 2025-06
Acadia Pharmaceuticals USD 123.66M 2.71M 2025-06
ALKERMES USD 153.87M 17.83M 2025-06
Alnylam Pharmaceuticals USD 323.31M 83.36M 2025-06
Amarin USD 36.57M 397K 2025-03
Amgen USD 1.69B 4M 2025-06
Baxter International USD 718M 15M 2025-06
Biogen USD 583.8M 11.3M 2025-06
BioMarin Pharmaceutical USD 232.28M 26.16M 2025-06
Bristol-Myers Squibb USD 1.71B 129M 2025-06
Eli Lilly USD 2.75B 390.8M 2025-06
Fujifilm JPY 196.64B 1.13B 2025-06
Gilead Sciences USD 1.36B 100M 2025-06
Ironwood Pharmaceuticals USD 33.33M 2.78M 2024-12
Merck USD 2.63B 104M 2025-06
Myriad Genetics USD 135.7M 300K 2025-03
Pacira USD 77.19M 9.58M 2025-06
Perrigo USD 273.1M 8.1M 2025-06
Pfizer USD 3.42B 406M 2025-06
PTC Therapeutics USD 85.26M 76.66M 2025-06
Regeneron Pharmaceuticals USD 634.2M 1.2M 2025-06
Sarepta Therapeutics USD 69.89M 63.74M 2025-06
Teva Pharmaceutical Industries USD 959M 40M 2025-06
Vertex Pharmaceuticals USD 424.6M 28.2M 2025-06
Xencor USD 15.11M 2.22M 2025-06
Zoetis USD 617M 54M 2025-06


Coherus Biosciences Despesas De Vendas E Administração - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Sep 2025.